Dr. Al-Aly is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
915 N Grand Blvd
Va Medical Center, Renal Section, Room 533
Saint Louis, MO 63106Phone+1 314-289-6485
Education & Training
SSM Health/Saint Louis University School of MedicineFellowship, Nephrology, 2003 - 2006- SSM Health/Saint Louis University School of MedicineResidency, Internal Medicine, 2000 - 2003
American University of Beirut Faculty of MedicineClass of 1999
Certifications & Licensure
MO State Medical License 2003 - 2026
CA State Medical License 2010 - 2020
Publications & Presentations
PubMed
- Learning from long COVID: conceptualising action to tackle infection-associated non-communicable diseases.Nisreen A Alwan, Ziyad Al-Aly
Lancet. 2025-02-01 - 2 citationsAuthor Correction: Mapping the effectiveness and risks of GLP-1 receptor agonists.Yan Xie, Taeyoung Choi, Ziyad Al-Aly
Nature Medicine. 2025-01-31 - Mapping the effectiveness and risks of GLP-1 receptor agonists.Yan Xie, Taeyoung Choi, Ziyad Al-Aly
Nature Medicine. 2025-01-20
Journal Articles
- Air Pollution and Kidney DiseaseZiyad Al-Aly, MD, American Society of Nephrology
- Analysis of the Global Burden of Disease Study Highlights the Global, Regional, and National Trends of Chronic Kidney Disease Epidemiology from 1990 to 2016Geetha Maddukuri, Ziyad Al-Aly, Kidney International
- Risk of Death Among Users of Proton Pump Inhibitors: A Longitudinal Observational Cohort Study of United States VeteransYan Yan, Ziyad Al-Aly, Tingting Li, Emergency Medicine Journal
Authored Content
- Risk of Death Among Users of Proton Pump Inhibitors: A Longitudinal Observational Cohort Study of United States VeteransJuly 2017
Press Mentions
On Its 5th Anniversary, Experts Address Questions About COVID-19February 7th, 2025- Here Are the Health Pros and Cons of GLP-1RA Weight Loss DrugsFebruary 7th, 2025
- Study Exposes COVID-19’s Dire Social Impact in BrazilFebruary 4th, 2025
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
